| Literature DB >> 33097810 |
Mukharram M Bikbov1, Gyulli M Kazakbaeva2, Timur R Gilmanshin2, Rinat M Zainullin2, Ildar F Nuriev2, Artur F Zaynetdinov2, Gulnara Z Israfilova2, Songhomitra Panda-Jonas3, Inga I Arslangareeva2, Ellina M Rakhimova2, Iulia A Rusakova2, Jost B Jonas4.
Abstract
To assess the prevalence of cataract and cataract surgery in a population from Russia, we conducted the population-based Ural Eye and Medical Study with 5899 participants (80.5% out of 7328 eligible individuals), with an age of 40 + years as the eligibility criterion. In the phakic population, the prevalence of nuclear, cortical, subcapsular cataract and any cataract was 38.0% [95% confidence interval (CI) 36.6, 39.3], 14.5% (95% CI 13.5, 15.5), 0.6% (95% CI 0.4, 0.8) and 44.6% (95% CI 43.2, 46.0), respectively. A higher prevalence of nuclear cataract was associated with older age [odds ratio (OR) 1.10; 95% CI 1.10, 1.11], the female sex (OR 1.27; 95% CI 1.08, 1.50), urban region (OR 2.00; 95% CI 1.71, 2.33), a low educational level (OR 0.93; 95% CI 0.88, 0.98), a high diastolic blood pressure (OR 1.01; 95% CI 1.001, 1.02), a low serum concentration of high-density lipoproteins (OR 0.91; 95% CI 0.84, 0.98), more smoking package years (OR 1.01; 95% CI 1.01, 1.02), chronic kidney disease (OR 1.02; 95% CI 1.10, 1.03), a short axial length (OR 0.93; 95% CI 0.86, 0.99), and a low prevalence of age-related macular degeneration (OR 0.72; 95% CI 0.57, 0.92). The prevalence of previous cataract surgery conducted in 354/5885 individuals (6.0%; 95% CI 5.4, 6.6) increased from 0.4% (95% CI 0.0, 1.0) in the age group of 40-45 years to 37.6% (95% CI 30.9, 44.4) in the age group of 80 + years. Cataract was the cause of moderate-to-severe vision impairment in 109 (1.8%) individuals and of blindness in three (0.05%) individuals. The prevalence of cataract and cataract-related MSVI and blindness were relatively high; subsequently, the prevalence of previous cataract surgery was relatively low in this population from Russia.Entities:
Mesh:
Year: 2020 PMID: 33097810 PMCID: PMC7584653 DOI: 10.1038/s41598-020-75313-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Prevalence (mean and 95% confidence interval) and mean stage of nuclear cataract, cortical cataract, subcapsular cataract and any cataract and status after cataract surgery stratified by age in the Ural Eye and Medical Study.
| Age group (years) | n | Nuclear cataract | Cortical cataract | Subcapsular posterior cataract | Any cataract | n | Cataract Surgery |
|---|---|---|---|---|---|---|---|
| 40–< 45 | 453 | 9.5% (6.8, 12.29) | 3.8% (2.0, 5.5) | 0.2% (0.0, 0.7) | 13.4 (10.3, 16.6) | 495 | 0.4% (0.0, 1.0) |
| 45–< 50 | 703 | 16.5% (13.8, 19.3) | 4.6% (3.0, 6.1) | 0.1% (0.0, 0.4) | 20.6% (17.6, 23.6) | 742 | 1.4% (0.0, 0.4) |
| 50–< 55 | 869 | 23.5% (20.7, 26.3) | 6.3% (4.7, 8.0) | 0.6% (0.1, 1.1) | 28.4% (25.4, 31.4) | 928 | 1.7% (0.9, 2.6) |
| 55–< 60 | 946 | 32.9% (30.0, 35.9) | 9.8% (7.9, 11.7) | 0.5% (0.1, 1.0) | 39.7%(36.6, 42.9) | 1039 | 2.1% (1.2, 3.0) |
| 60–< 65 | 803 | 41.7% (38.3, 45.1) | 15.2% (12.7, 17.7) | 0.6% (0.1, 1.2) | 51.8% (48.3, 55.3) | 920 | 3.5% (2.3, 4.7) |
| 65–< 70 | 661 | 61.3% (57.6, 65.0) | 25.1% (21.8, 28.4) | 0.9% (0.2, 1.6) | 69.7% (66.2, 73.3) | 789 | 6.2% (4.5, 7.9) |
| 70–< 75 | 268 | 69.0% (63.5, 74.6) | 30.2% (24.7, 35.8) | 1.1% (0.0, 2.4) | 77.6% (72.6, 82.6) | 359 | 17.0% (13.1, 20.9) |
| 75–< 80 | 283 | 82.3% (77.9, 86.8) | 42.8% (77.9, 86.8) | 1.4% (0.0, 2.8) | 88.7% (85.0, 92.4) | 411 | 23.1% (19.0, 27.2) |
| 80 + | 114 | 91.2% (86.0, 96.5) | 46.5% (37.2, 55.8) | 0.9% (0.0, 2.6) | 96.5% (93.1, 99.9) | 202 | 37.6% (30.9, 44.4) |
| Total | 5100 | 38.0% (36.6, 39.3) | 14.5% (13.5, 15.5) | 0.6% (0.4, 0.8) | 44.6% (43.2, 46.0) | 5885 | 6.0% (5.4, 6.6) |
Figure 1Prevalence of cataract surgery in the Ural Eye and Medical Study.
Figure 2Prevalence of nuclear cataract in the phakic population of the Ural Eye and Medical Study.
Figure 3Prevalence of cortical cataract in the phakic population of the Ural Eye and Medical Study.
Associations (multivariable analysis) between the prevalence of nuclear cataract and systemic and ocular parameters in the phakic population of the Ural Eye and Medical Study.
| Parameter | Odds ratio | 95% confidence interval | |
|---|---|---|---|
| Age (years) | < 0.001 | 1.10 | 1.10, 1.11 |
| Male/female sex | 0.004 | 1.27 | 1.08, 1.50 |
| Urban region of habitation | < 0.001 | 2.00 | 1.71, 2.33 |
| Serum concentration of high-density lipoproteins (mmol/L) | 0.02 | 0.91 | 0.84, 0.98 |
| Diastolic blood pressure (mmHg) | 0.02 | 1.01 | 1.001, 1.02 |
| Level of education | 0.006 | 0.93 | 0.88, 0.98 |
| Chronic kidney disease stage | 0.002 | 1.02 | 1.01, 1.03 |
| Smoking package years | < 0.001 | 1.01 | 1.01, 1.02 |
| Age-related macular degeneration, prevalence | 0.006 | 0.72 | 0.57, 0.92 |
| Axial length (mm) | 0.03 | 0.93 | 0.86, 0.99 |
Associations (multivariable analysis) between the prevalence of cortical cataract and systemic and ocular parameters in the phakic population of the Ural Eye and Medical Study.
| Parameter | Odds ratio | 95% confidence interval | |
|---|---|---|---|
| Age (years) | < 0.001 | 1.10 | 1.09, 1.11 |
| Male/female sex | < 0.001 | 1.44 | 1.19, 1,74 |
| Urban region of habitation | < 0.001 | 0.49 | 0.39, 0.60 |
| Serum concentration of high-density lipoproteins (mmol/L) | 0.002 | 0.84 | 0.75, 0.94 |
| Age-related macular degeneration, prevalence | 0.01 | 1.37 | 1.07, 1.76 |